Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9784
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRathod, Gaurav P.-
dc.date.accessioned2021-02-12T10:42:09Z-
dc.date.available2021-02-12T10:42:09Z-
dc.date.issued2020-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9784-
dc.descriptionGuided by Prof. Manjunath Ghateen_US
dc.description.abstractMonoacyl glycerol lipase (MAGL) enzyme belongs to Serine Hydrolase superfamily. MAGL play a role in catabolism of 2-AG (2-Arachidonyl glycerol). 2-AG is a neurotransmitter in endocannabinoid system. Which have some physiological actions. MAGL gives the Arachidonic acid and Glycerol by degrading 2-AG. This Arachidonic acid producing pro-inflammatory agents like prostaglandins, throxanes. So, the major role of MAGL inhibitors as anti-inflammatory, antinociceptive and anti-cancer agents. Recent studies suggest that the repeated administration of MAGL inhibitor will lost its activity and produced cross tolerance to cannabinoid receptor (CB1). In this review we discuss about the Biochemical and Physiological role of MAGL inhibitors, and various scaffolds which are discovered as potent for inhibition of MAGLen_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR01028;-
dc.subjectPPR01028en_US
dc.subjectB. Pharm Project Reporten_US
dc.subjectMedicinal Chemistryen_US
dc.subjectMonoacyl glycerol lipase (MAGL)en_US
dc.subjectneurotransmitteren_US
dc.subjectcannabinoid receptoren_US
dc.titleA Review on MAGL Inhibitoren_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR01028.pdfPPR010281.02 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.